Table 4.
Use of Nonaspirin NSAIDs and Acetaminophen and Incidence of Ovarian Cancer in the Nurses’ Health Study (1990–2004) and Nurses’ Health Study-II (1989–2005)
Nonaspirin NSAIDs |
Acetaminophen |
|||||||||
Cases, no.a | Hazard Ratiob | 95% Confidence Intervalb | Hazard Ratioc | 95% Confidence Intervalc | Cases, no.a | Hazard Ratiob | 95% Confidence Intervalb | Hazard Ratioc | 95% Confidence Intervalc | |
Use ≥2 times/week | ||||||||||
Never | 267 | 1.00 | 1.00 | 295 | 1.00 | 1.00 | ||||
Past | 75 | 1.13 | 0.87, 1.48 | 1.12 | 0.86, 1.47 | 54 | 0.98 | 0.72, 1.32 | 0.98 | 0.73, 1.33 |
Current | 119 | 0.81 | 0.65, 1.02 | 0.81 | 0.64, 1.01 | 112 | 1.15 | 0.92, 1.43 | 1.14 | 0.92, 1.43 |
No. of days/weekd | ||||||||||
<2 | 341 | 1.00 | 1.00 | 360 | 1.00 | 1.00 | ||||
2–4 | 34 | 0.80 | 0.56, 1.14 | 0.80 | 0.56, 1.14 | 26 | 0.88 | 0.59, 1.31 | 0.87 | 0.58, 1.30 |
≥5 | 26 | 0.90 | 0.60, 1.35 | 0.88 | 0.59, 1.32 | 18 | 1.15 | 0.71, 1.85 | 1.13 | 0.70, 1.82 |
Ptrende | 0.71 | 0.64 | 0.64 | 0.70 | ||||||
Duration of regular use, year(s)f | ||||||||||
<1 | 280 | 1.00 | 1.00 | 312 | 1.00 | 1.00 | ||||
1–<2 | 61 | 1.17 | 0.88, 1.55 | 1.17 | 0.88, 1.56 | 56 | 1.20 | 0.87, 1.66 | 1.19 | 0.86, 1.65 |
2–<5 | 64 | 1.03 | 0.78, 1.36 | 1.02 | 0.77, 1.35 | 54 | 0.97 | 0.66, 1.42 | 0.96 | 0.65, 1.40 |
≥5 | 56 | 0.93 | 0.68, 1.26 | 0.92 | 0.67, 1.25 | 39 | 0.88 | 0.56, 1.38 | 0.86 | 0.55, 1.37 |
Ptrende | 0.58 | 0.53 | 0.83 | 0.83 |
Abbreviation: NSAID, nonsteroidal antiinflammatory drug.
Numbers may not add up to the total number of cases because of missing information on exposure.
Models stratified jointly by age in months and by 2-year time cycles.
Models stratified jointly by age in months and by 2-year time cycles and additionally adjusted for duration of oral contraceptive use, parity, tubal ligation, menopausal status, and current postmenopausal hormone use.
Cumulative average days per week; information available from 1990 to 2004 (Nurses’ Health Study) and from 1995 to 2005 (Nurses’ Health Study-II).
P values (Wald statistics) modeling categories of use linearly and continuous measures of frequency (days/week) and duration (years).
Duration of regular use since 1990 (Nurses’ Health Study)/1989 (Nurses’ Health Study-II); information available from 1990 to 2004 (Nurses’ Health Study) and from 1989 to 2005 (Nurses’ Health Study-II).